NCT06853977View on ClinicalTrials.gov

Understanding the Role of Monoaminergic Neurotransmitters in Cognitive Functions Using Fast-cyclic Voltammetry in Patients With Neurological and Psychiatric Diseases Eligible for Neurosurgical Treatment (COGAMINE)

NAActive, not recruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

February 20, 2025

Primary Completion Date

June 30, 2035

Study Completion Date

June 30, 2035

Conditions

Neurological Diseases or ConditionsPsychiatric DiseasesCandidates for Deep Brain StimulationCandidates for Invasive S-EEGCandidates for Awake Surgery

Interventions

BEHAVIORAL

Cognitive tasks

Cognitive tasks performed during intracerebral voltammetric recordings

Trial Locations (1)

Unknown

Groupe Hospitalo-Universitaire Paris Psychiatrie & Neurosciences, Paris

All Listed Sponsors

lead

Centre Hospitalier St Anne

OTHER

NCT06853977 - Understanding the Role of Monoaminergic Neurotransmitters in Cognitive Functions Using Fast-cyclic Voltammetry in Patients With Neurological and Psychiatric Diseases Eligible for Neurosurgical Treatment (COGAMINE) | Biotech Hunter | Biotech Hunter